IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)

Clinical trial NCT03952065 · RECRUITING

Trial details

NCT number: NCT03952065
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Head/Neck Neoplasm

Start date: 2019-01-01
Primary completion: 2029-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.